Showing 8781-8790 of 23044 results for "".
Knocking on Heaven's Door: The Path to a Better Way of Death
https://reachmd.com/programs/book-club/knocking-on-heavens-door-the-path-to-a-better-way-of-death/7034/Host Dr. Maurice Pickard welcomes award-winning journalist Katy Butler. In her book, Knocking on Heaven's Door, she speaks for the twenty-four million Americans who are helping their parents through their final years. Ms. Butler's memoir and investigation reports on the modern complications of technBreaking Ground in Bone Health: Key Takeaways from ISO 2025
https://reachmd.com/programs/frontlines-osteoporosis/breaking-ground-in-bone-health-key-takeaways-from-iso-2025/32338/The 2025 Interdisciplinary Symposium on Osteoporosis (ISO) featured expert insights on the most pressing issues in bone health, like innovations in diagnosis and treatment, post-fracture care, long-term management, and so much more. Here to share the key highlights and takeaways from ISO 2025 is AmiWomen and Heart Disease: A Different Illness?
https://reachmd.com/programs/clinicians-roundtable/women-and-heart-disease-a-different-illness/2642/Is heart disease in women the same as in men? Should we have different treatment protocols based on gender? Dr. R. Claire Friend joins host Dr. Leslie Lundt to discuss novel ways of looking at women and heart disease.Sudden Cardiac Death Prevention: ICD Indications
https://reachmd.com/programs/clinicians-roundtable/sudden-cardiac-death-prevention-icd-indications/3681/Patients with advanced heart failure are at increased risk for sudden cardiac arrest, but many of them are not receiving ICD therapy. Dr. Jeanne Poole, professor of medicine and cardiology at the University of Washington, Seattle, will review with host Dr. Matthew Sorrentino the indications for ICDThe Pause: The Most Powerful Tool in Speaking
https://reachmd.com/programs/speaking-of/pause-most-powerful-tool-speaking/10109/Utilizing "the pause" correctly is key to invoking different effects and emotions in your audience.Cured: How the Berlin Patients Defeated HIV and Forever Changed Medical Science
https://reachmd.com/programs/book-club/cured-how-berlin-patients-defeated-hiv-forever-changed-medical-science/7430/A cure for HIV? Two men, known in medical journals as the Berlin Patients, were cured of HIV in distinct yet related ways. The two patients’ disparate cures came twelve years apart, but Nathalia Holt, an award-winning scientist at the forefront of HIV research, connects the molecular dots of these cLooking Beyond LDL to Reduce Cardiovascular Events
https://reachmd.com/programs/lipid-luminations/looking-beyond-ldl-to-reduce-cardiovascular-events/3425/To effectively reduce one's cardiovascular risk, recent studies suggest it is necessary to treat multiple factors and not just the patient's LDL number. Dr. Brown discusses with host Dr. Larry Kaskel how studies that used a multi-factor approach, such as the Steno studies and the Champ study,Why Are There So Few Women in Neurosurgery?
https://reachmd.com/programs/clinicians-roundtable/why-are-there-so-few-women-in-neurosurgery/3449/More than half of all students accepted into medical schools are women, but only a fraction of neurosurgeons are female. Dr. Gail Rosseau, of the American Association of Neurological Surgeons, tells host Bruce Japsen about a new paper that highlights these challenges and provides recoIs the Metabolic Syndrome More Than Just the Sum of Its Parts?
https://reachmd.com/programs/clinicians-roundtable/is-the-metabolic-syndrome-more-than-just-the-sum-of-its-parts/3183/The Metabolic Syndrome has been associated with an increased risk for developing diabetes and cardiovascular disease. Dr. Dariush Mozaffarian from the Division of Cardiovascular Medicine at Harvard Medical School will discuss his latest research on the Metabolic Syndrome in older adults highlightingA Resurgence of Stents
https://reachmd.com/programs/diabetes-discourse/a-resurgence-of-stents/4693/Diabetes is strongly linked with a number of risk factors for coronary problems such as high blood pressure, high cholesterol, abdominal obesity that significantly increases the risk of heart attack and stroke. Recent studies indicate that new drug-eluting stents are a reasonable option for the diab